General Pharmacology — MCQs

General Pharmacology Indian Medical PG Practice Questions and MCQs

Question 391: Which of the following is not a pro-drug?

A. Becampicillin
B. Levodopa
C. Penicillin (Correct Answer)
D. Enalapril

Explanation: **Explanation:** A **prodrug** is a pharmacologically inactive compound that must undergo metabolic conversion (usually in the liver or gut) into an active metabolite to exert its therapeutic effect. **Why Penicillin G is the correct answer:** Penicillin G (Benzylpenicillin) is an **active drug**. It does not require metabolic activation to exert its antibacterial effect; it directly binds to Penicillin-Binding Proteins (PBPs) to inhibit bacterial cell wall synthesis. Therefore, it is not a prodrug. **Analysis of Incorrect Options:** * **Becampicillin:** It is an ester prodrug of **Ampicillin**. It was developed to improve oral bioavailability and reduce gastrointestinal side effects (like diarrhea) by being absorbed more efficiently before being hydrolyzed into active ampicillin in the intestinal wall or blood. * **Levodopa:** It is the metabolic precursor to **Dopamine**. Dopamine cannot cross the blood-brain barrier (BBB); however, Levodopa crosses the BBB via amino acid transporters and is then converted to active dopamine by the enzyme DOPA decarboxylase. * **Enalapril:** Most ACE inhibitors (except Captopril and Lisinopril) are prodrugs. Enalapril is converted by hepatic esterases into its active form, **Enalaprilat**, which inhibits the Angiotensin-Converting Enzyme. **NEET-PG High-Yield Pearls:** * **Mnemonic for Prodrugs:** "**A**ll **P**ilots **C**an **L**ead **D**rummers **E**very **S**unday" (**A**cyclovir/ACEi, **P**roguanil/PPIs, **C**yclophosphamide, **L**evodopa, **D**ipivefrin, **E**nalapril, **S**ulindac/Statins). * **Exceptions to remember:** **Captopril** and **Lisinopril** are the only two ACE inhibitors that are NOT prodrugs. * **Active Metabolites:** Some drugs are active themselves but also have active metabolites (e.g., Diazepam → Nordiazepam). These are distinct from prodrugs, which are inactive initially.

Question 392: Which of the following drugs is an immunostimulant?

A. Prednisolone
B. Levamisole (Correct Answer)
C. Cyclosporine
D. Thalidomide

Explanation: **Explanation:** **Levamisole** is the correct answer because it is a classic example of a non-specific **immunostimulant**. Originally developed as an anthelmintic, it was found to restore the immune function of T-lymphocytes and macrophages when they are suppressed. It "primes" the immune system by enhancing T-cell mediated immunity and phagocytosis. While its use has declined due to side effects like agranulocytosis, it remains a high-yield prototype for immunostimulants in pharmacology exams. **Analysis of Incorrect Options:** * **Prednisolone (A):** A potent glucocorticoid that acts as a broad-spectrum **immunosuppressant**. It inhibits the transcription of many pro-inflammatory genes and cytokines (like IL-1 and IL-6). * **Cyclosporine (C):** A **calcineurin inhibitor** that specifically suppresses T-cell activation by inhibiting the synthesis of Interleukin-2 (IL-2). It is primarily used to prevent organ transplant rejection. * **Thalidomide (D):** An **immunomodulator** with predominantly inhibitory effects. It suppresses Tumor Necrosis Factor-alpha (TNF-α) and is used in conditions like Erythema Nodosum Leprosum (ENL) and Multiple Myeloma. **NEET-PG High-Yield Pearls:** * **Levamisole Clinical Use:** Historically used in colon cancer (with 5-Fluorouracil) and nephrotic syndrome to reduce relapse rates. * **Other Immunostimulants:** Include BCG vaccine (used intravesically for bladder cancer), Interferons (IFN-α for Hepatitis B/C), and Interleukin-2 (Aldesleukin). * **Mechanism Tip:** Remember that most drugs in transplant medicine (the "C"s: Cyclosporine, Cyclophosphamide, Corticosteroids) are *suppressants*, not stimulants.

Question 393: Phocomelia is caused by ingestion of which substance during pregnancy?

A. Steroids
B. Tetracycline
C. Thalidomide (Correct Answer)
D. Barbiturates

Explanation: **Explanation** **Correct Option: C. Thalidomide** Thalidomide is a potent teratogen that causes **Phocomelia**, a condition characterized by "seal-like limbs" where the long bones of the arms or legs are extremely shortened or absent, with hands or feet attached directly to the trunk. The underlying mechanism involves the inhibition of **angiogenesis** (vessel growth) in the developing limb buds and the degradation of transcription factors (like SALL4) via the cereblon E3 ubiquitin ligase complex. Originally marketed in the 1950s as a sedative and anti-emetic for morning sickness, it led to a global tragedy, resulting in thousands of infants born with limb deformities. **Analysis of Incorrect Options:** * **A. Steroids:** Maternal steroid use is occasionally associated with an increased risk of **cleft lip and palate**, though they are generally considered relatively safe in specific dosages. * **B. Tetracycline:** These are known for causing **discoloration of deciduous teeth** (yellow-brown staining) and enamel hypoplasia because they chelate calcium in developing bones and teeth. * **C. Barbiturates:** While some (like Phenobarbital) are associated with neonatal withdrawal or vitamin K deficiency, they do not cause phocomelia. **High-Yield Clinical Pearls for NEET-PG:** * **Thalidomide Today:** It is currently used under strict regulation for **Multiple Myeloma** and **Erythema Nodosum Leprosum (ENL)**. * **Critical Period:** The risk for phocomelia is highest when taken between the **24th and 36th day** of gestation. * **Other Teratogens:** * **Valproate:** Neural tube defects. * **Warfarin:** Fetal Warfarin Syndrome (stippled epiphyses, nasal hypoplasia). * **Isotretinoin:** Severe craniofacial and CNS defects (requires "iPLEDGE" program).

Question 394: Combination of ampicillin and gentamicin is an example of what type of drug interaction?

A. Indifference
B. Synergy (Correct Answer)
C. Antagonism
D. Bacterial symbiosis

Explanation: **Explanation:** The combination of **Ampicillin** (a Beta-lactam) and **Gentamicin** (an Aminoglycoside) is a classic example of **Synergy** (specifically, supra-additive effect). 1. **Why Synergy is Correct:** Synergy occurs when the combined effect of two drugs is greater than the sum of their individual effects ($1 + 1 > 2$). * **Mechanism:** Ampicillin inhibits bacterial cell wall synthesis. This damage to the cell wall increases the permeability of the bacteria, allowing Gentamicin (which acts on the 30S ribosome) to enter the cell more easily. * Without the beta-lactam, aminoglycosides often struggle to penetrate certain bacteria (like *Enterococci*). Together, they produce a potent bactericidal effect. 2. **Why Other Options are Incorrect:** * **Indifference:** This occurs when the combined effect is equal to the effect of the more potent drug alone ($1 + 1 = 1$). * **Antagonism:** This occurs when one drug decreases the action of another ($1 + 1 < 1$). For example, combining a bacteriostatic drug (Tetracycline) with a bactericidal drug (Penicillin) often results in antagonism. * **Bacterial Symbiosis:** This is a biological term referring to a relationship between two organisms; it is not a pharmacological term for drug interactions. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Use:** This combination is the gold standard for treating **Enterococcal Endocarditis** and is frequently used in neonatal sepsis. * **Rule of Thumb:** Generally, combining two bactericidal drugs (like this case) leads to synergy, while combining a bactericidal with a bacteriostatic drug leads to antagonism. * **Sequential Blockade:** Another form of synergy (e.g., Sulfamethoxazole + Trimethoprim) where two drugs inhibit successive steps in the same metabolic pathway.

Question 395: All of the following statements about lignocaine are true EXCEPT:

A. It blocks active sodium channels with more affinity than resting sodium channels.
B. It can cause cardiotoxicity.
C. It is given orally for treatment of cardiac arrhythmias. (Correct Answer)
D. Adrenaline increases the duration of action of lignocaine when used for infiltration anaesthesia.

Explanation: ### Explanation **Correct Answer: C. It is given orally for treatment of cardiac arrhythmias.** **Why Option C is the correct answer (The "Except" statement):** Lignocaine (Lidocaine) is a Class IB antiarrhythmic agent that undergoes **extensive first-pass metabolism** in the liver. If administered orally, its bioavailability is extremely low (approx. 30%), and its metabolites (monoethylglycinexylidide) can be toxic to the CNS. Therefore, for systemic effects like treating ventricular arrhythmias (e.g., post-MI), it must be administered **intravenously**. **Analysis of Incorrect Options:** * **Option A:** Lignocaine is a state-dependent sodium channel blocker. It has a higher affinity for **active (open) and inactivated states** of the sodium channel rather than the resting state. This property allows it to selectively block rapidly firing tissues (like ischemic myocardium). * **Option B:** While lignocaine is safer for the heart than bupivacaine, high systemic doses can lead to **cardiotoxicity**, manifesting as bradycardia, hypotension, and arrhythmias. * **Option C:** **Adrenaline (Epinephrine)** is a vasoconstrictor. When added to local anaesthetics for infiltration, it reduces local blood flow, thereby slowing the systemic absorption of lignocaine. This **increases the duration of action** and reduces systemic toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Lignocaine is the DOC for **ventricular arrhythmias** occurring during cardiac surgery or post-Myocardial Infarction. * **CNS Toxicity:** The initial signs of lignocaine toxicity are often neurological (perioral numbness, metallic taste, tremors, and seizures). * **Adrenaline Contraindication:** Never use lignocaine with adrenaline for "end-artery" areas like the **fingers, toes, tip of the nose, or penis**, as it can cause ischemic necrosis/gangrene. * **Metabolism:** It is metabolized by hepatic CYP3A4.

Question 396: Who are typically enrolled as participants in Phase-I clinical trials?

A. Patients
B. Volunteers (Correct Answer)
C. Selected patients
D. All of the above

Explanation: **Explanation:** **Phase I Clinical Trials** are the first stage of testing a new investigational drug in humans. The primary objective is to determine **Safety and Tolerability** (Maximum Tolerated Dose) and to study the drug’s **Pharmacokinetics** (ADME) and **Pharmacodynamics**. **Why "Volunteers" is the correct answer:** In Phase I, the drug is typically administered to a small group (20–80) of **healthy human volunteers**. Since the therapeutic efficacy is not yet known and the risk of toxicity is high, it is ethically preferred to test the drug on healthy individuals who do not have the target disease. This allows researchers to observe the drug's effects on normal physiological functions without the interference of disease-related variables. **Analysis of Incorrect Options:** * **A & C (Patients/Selected Patients):** Patients are generally not used in Phase I because the goal is not to treat a disease but to assess safety. However, there is a **critical exception**: for highly toxic drugs (e.g., **Anti-cancer drugs** or **Anti-HIV drugs**), Phase I trials are conducted on "Selected Patients" because it is unethical to expose healthy volunteers to such toxicities. Since the question asks for the "typical" participant, healthy volunteers remain the standard answer. * **D (All of the above):** While patients are used in specific exceptions, the standard protocol for the vast majority of drugs involves healthy volunteers. **High-Yield NEET-PG Pearls:** * **Phase 0:** Also known as **Microdosing** studies; uses sub-therapeutic doses in humans to study PK. * **Phase I:** Safety, Tolerability, PK/PD. (Healthy Volunteers). * **Phase II:** Therapeutic **Efficacy** and Dose-ranging. (Small group of Patients). * **Phase III:** Therapeutic **Confirmation** and Comparison with existing treatments. (Large group of Patients; Multicentric). * **Phase IV:** **Post-marketing Surveillance**; detects rare side effects (e.g., Phocomelia).

Question 397: Which is the complete neuromuscular blocking agent with the shortest duration of action?

A. Rocuronium
B. Pipecuronium
C. Mivacurium (Correct Answer)
D. Pancuronium

Explanation: **Explanation:** The duration of action of non-depolarizing neuromuscular blocking agents (NMBAs) is primarily determined by their metabolism and elimination pathways. **Why Mivacurium is correct:** Mivacurium is a benzylisoquinoline derivative and is the **shortest-acting** non-depolarizing NMBA. Its brief duration (approximately 12–18 minutes) is due to its rapid hydrolysis by **plasma cholinesterase** (pseudocholinesterase), similar to the mechanism of succinylcholine. This makes it unique among non-depolarizing agents, which typically have longer durations. **Analysis of Incorrect Options:** * **Rocuronium:** An intermediate-acting steroid-based NMBA. It has the fastest *onset* of action among non-depolarizers (useful for rapid sequence intubation) but a duration of 30–40 minutes. * **Pipecuronium:** A long-acting NMBA with a duration exceeding 60–90 minutes. It is rarely used in modern practice due to its prolonged effect. * **Pancuronium:** A long-acting steroid-based NMBA. It is known for causing vagolytic effects (tachycardia) and has a duration of 60–120 minutes. **High-Yield Clinical Pearls for NEET-PG:** * **Shortest Acting (Overall):** Succinylcholine (Depolarizing agent; ~5–10 mins). * **Shortest Acting (Non-depolarizing):** Mivacurium. * **Fastest Onset (Non-depolarizing):** Rocuronium. * **Hoffman Elimination:** Atracurium and Cisatracurium undergo spontaneous degradation (independent of renal/hepatic function), making them drugs of choice in **liver or kidney failure**. * **Mivacurium Caution:** Its action is prolonged in patients with **pseudocholinesterase deficiency**. It can also cause histamine release if injected rapidly.

Question 398: Insulin acts via which receptor?

A. Ionotropic receptor
B. Enzymatic receptor (Correct Answer)
C. Metabotropic receptor
D. Nuclear receptor

Explanation: **Explanation:** The insulin receptor is a classic example of an **Enzymatic (Catalytic) receptor**, specifically a **Receptor Tyrosine Kinase (RTK)**. It is a heterotetramer consisting of two extracellular α-subunits (for binding) and two transmembrane β-subunits. Upon insulin binding, the β-subunits undergo autophosphorylation, activating the intrinsic tyrosine kinase enzyme. This triggers a signaling cascade involving Insulin Receptor Substrates (IRS-1/2) and the PI3K/Akt pathway, which facilitates glucose uptake via GLUT-4 translocation. **Why other options are incorrect:** * **Ionotropic receptors (Option A):** These are ligand-gated ion channels (e.g., Nicotinic ACh receptors, GABA-A). They act within milliseconds by changing membrane potential, which is not the mechanism for metabolic hormones like insulin. * **Metabotropic receptors (Option C):** Also known as G-Protein Coupled Receptors (GPCRs), these act via second messengers like cAMP or IP3/DAG (e.g., Glucagon, Adrenaline). Insulin does not utilize G-proteins for its primary signaling. * **Nuclear receptors (Option D):** These are intracellular receptors for lipid-soluble ligands (e.g., Steroids, Thyroid hormone, Vitamin D). They act as transcription factors. Insulin is a peptide hormone and cannot cross the plasma membrane. **High-Yield NEET-PG Pearls:** * **MAP Kinase Pathway:** Insulin also uses this pathway for its growth-promoting and mitogenic effects. * **Other RTK ligands:** Growth factors (EGF, PDGF, NGF) and Erythropoietin also use enzymatic receptors. * **JAK-STAT Pathway:** A subtype of enzymatic receptors where the kinase is not intrinsic but "recruited" (e.g., Growth Hormone, Prolactin, Cytokines).

Question 399: Which of the following statements is true regarding inverse agonists?

A. Binds to a receptor and causes the intended action.
B. Binds to a receptor and causes an action opposite to that of an agonist. (Correct Answer)
C. Binds to a receptor and causes no action.
D. Binds to a receptor and causes a submaximal action.

Explanation: ### Explanation **1. Why Option B is Correct:** The concept of inverse agonism is based on the **Two-State Receptor Model**, which proposes that receptors exist in an equilibrium between an **inactive (Ri)** and an **active (Ra)** state, even in the absence of a ligand (constitutive activity). * An **Inverse Agonist** has a higher affinity for the **inactive state (Ri)**. * By stabilizing the inactive form, it shifts the equilibrium away from the active state, thereby reducing the basal/constitutive activity of the receptor. This results in a pharmacological effect that is **directionally opposite** to that of a full agonist. **2. Analysis of Incorrect Options:** * **Option A:** Describes a **Full Agonist**, which binds to the active state (Ra) and produces the maximum possible response. * **Option C:** Describes a **Competitive Antagonist** (or Neutral Antagonist). These bind to the receptor but do not shift the equilibrium; they simply prevent agonists from binding. They have "zero" intrinsic activity. * **Option D:** Describes a **Partial Agonist**, which binds to the receptor but produces a submaximal response even at 100% receptor occupancy (Intrinsic activity between 0 and 1). **3. NEET-PG High-Yield Clinical Pearls:** * **Intrinsic Activity (α):** * Full Agonist: +1 * Antagonist: 0 * Inverse Agonist: **–1** * Partial Agonist: Between 0 and +1 * **Classic Examples:** * **Beta-carbolines** act as inverse agonists at GABA-A receptors (causing convulsions, whereas GABA/Benzodiazepines are sedative). * Many drugs previously thought to be antagonists are now classified as inverse agonists (e.g., **Losartan**, **Famotidine**, and **Metoprolol**). * **Key Distinction:** An antagonist can only work in the presence of an agonist, but an inverse agonist can exert an effect in the absence of any agonist by suppressing constitutive activity.

Question 400: Which of the following is/are prodrug(s)?

A. Proguanil
B. Azathioprine
C. Prontosil
D. All the above (Correct Answer)

Explanation: **Explanation:** A **prodrug** is a pharmacologically inactive compound that is converted into an active metabolite within the body (usually via the liver) to exert its therapeutic effect. This strategy is often used to improve bioavailability, reduce toxicity, or prolong the duration of action. * **Proguanil (Option A):** This is an antimalarial drug that is inactive in its parent form. It is converted by the hepatic enzyme **CYP2C19** into its active metabolite, **Cycloguanil**, which inhibits dihydrofolate reductase in the malaria parasite. * **Azathioprine (Option B):** This is an immunosuppressant used in organ transplants and autoimmune diseases. It is a prodrug that is non-enzymatically converted into **6-Mercaptopurine (6-MP)**, which then undergoes further activation to inhibit purine synthesis. * **Prontosil (Option C):** Historically significant as the first sulfonamide, Prontosil is a red dye that has no antibacterial activity *in vitro*. However, *in vivo*, it is split by bacterial enzymes in the gut to release the active component, **Sulfanilamide**. Since all three drugs require metabolic activation to become effective, **Option D (All the above)** is the correct answer. ### **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Prodrugs:** "All Compounds Can Produce Efficient Medication" (**A**CE inhibitors except Captopril/Lisinopril, **C**yclophosphamide, **C**lopidogrel, **P**roguanil/Prontosil, **E**nalapril, **M**ethyldopa/Levodopa). * **Exceptions to remember:** Most ACE inhibitors are prodrugs **EXCEPT Captopril and Lisinopril**. * **Active Metabolites:** Some drugs are active themselves but also have active metabolites (e.g., Diazepam → Nordiazepam). These are **not** classified as prodrugs.

Practice by Chapter

Pharmacokinetics: Absorption and Distribution

Practice Questions

Pharmacokinetics: Metabolism and Excretion

Practice Questions

Pharmacodynamics and Receptor Theory

Practice Questions

Drug-Receptor Interactions and Dose-Response

Practice Questions

Pharmacogenetics and Personalized Medicine

Practice Questions

Adverse Drug Reactions and Toxicity

Practice Questions

Drug Interactions

Practice Questions

Drug Development and Regulation

Practice Questions

Pediatric and Geriatric Pharmacology

Practice Questions

Placental Transfer and Lactation

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free